A prospective study identifies echocardiographic markers that may improve screening for cardiac sarcoidosis when combined with symptom and rhythm data. The work reports that findings such as left ventricular dilatation and basal septal thinning can add signal for identifying patients who might otherwise be missed. Because cardiac sarcoidosis can present with variable findings, the study emphasizes a multimodal screening approach—pairing imaging phenotypes with clinical and rhythm information to refine risk detection. For cardiology and translational teams, the findings are actionable: they support protocol refinement for echocardiography interpretation and could inform selection of who receives further confirmatory testing. The prospective framing strengthens the screening relevance compared with purely retrospective marker reports, though the study details beyond the headline-level description are limited in the provided record.